51 min ago | M2.com
OSI says Tarceva to be reviewed by FDA committee for use as...
OSI says Tarceva to be reviewed by FDA committee for use as first-line maintenance therapy in advanced NSCLC Published in M2Europharma on Monday, 16 November 2009 at 21:09 GMT 16 November 2009 - US-based OSI Pharmaceuticals Inc said today that FDA's Oncologic Drugs Advisory Committee will review the use of Tarceva as a first-line maintenance ...
China Biotech Week in Review: International Initiatives
There was a particularly strong international flair to news from China biopharma last week.
Galleon Is Said to Have Liquidated More Than 90% of Hedge-Fund Investments
Galleon Group LLC, the hedge-fund firm thata s liquidating after billionaire founder Raj Rajaratnam was charged with insider trading, sold more than 90 percent of its investments, according to a person familiar with the matter.
ETFs Reshaped Ahead of Regulation
As negative sentiment against Wall Street snowballs and a new trading scandal takes shape, it is important to look back to 1986 and reflect on what's changed and what hasn't. While traders at the Galleon Group began unwinding positions in stocks like eBay , Apple and OSI Pharmaceuticals in the wake of Raj Rajaratnam's arrest, the filming of "Wall ...
AllPennyStocks.com News: Large & Small-Cap Companies Making Big...
AllPennyStocks.com News: Large & Small-Cap Companies Making Big Strides In The Fight Against Cancer MISSISSAUGA, Ontario, October 19, 2009 -- AllPennyStocks.com Media, Inc.
News and FDA Updates for Dynavax
Pasadena, CA - 10/22/09 - BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.
OSI Pharma 3rd-qtr profit falls on costs, taxes
Shares of drug developer OSI Pharmaceuticals Inc. rallied Thursday after the company posted better-than-expected revenue in the third quarter, even as its profit plunged on higher costs and taxes.
OSI Pharmaceuticals, Inc. Q3 2009 Earnings Call Transcript
OSI Pharmaceuticals, Inc. October 21, 2009 5:00 pm ET Executives Kathy Galante a ' Senior Director, Investor and Public Relations Pierre Legault a ' EVP, CFO and Treasurer Gabriel Leung a ' EVP and President, Pharmaceutical Business Colin Goddard a ' CEO Analysts Harry [ph] a ' JP Morgan Vlad Agassi [ph] a ' Cowen Presentation Operator Please stand ...
Simcere to Develop OSI Pharmaceutical Cancer Drug in China
Simcere Pharmaceutical Group has acquired the China rights to a dual-mechanism cancer drug from OSI Pharmaceuticals, Inc.
Westchester Slowly Lures Biotech Companies
After more than six years of courting the biotech industry, Westchester County is getting some positive results.
Groundbreaking Agreement Brings OSI-930 to China
In a unique agreement that could become a model for research and development cooperation between Chinese pharmaceutical companies and those in other countries, Long Island, NY based OSI Pharmaceuticals and Nanjing, China based Simcere Pharmaceutical Group announced a collaboration to develop, manufacture, and market OSI's OSI-930 KDR/Kit inhibitor ...
Huron, others could get caught in Galleon Group problems
The stocks of a few small companies could be unintended victims of Galleon Group's problems.
Pfizer Suspends Lung Cancer Study
The news is another setback for Pfizer as it makes a big push into cancer drugs.
Revolutionary drug could be new hope for adrenal cancer patients
The TGen Clinical Research Services clinic is located in The Virginia G. Piper Cancer Center at Scottsdale Healthcare Shea Medical Center in Scottsdale, Arizona.
BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.
Slichenmyer named Aveo's chief medical officer
Cancer-focused biotech company Aveo Pharmaceuticals Inc. reports it has appointed William Slichenmyer as chief medical officer.
Suffolk County Executive Steve Levy on Tuesday said the region has successfully attracted new, high-paying jobs in the region, though the loss of young people remains a serious threat to future economic growth.
OSI Pharmaceuticals, Inc. announced today that OSI Management will present at the Morgan Stanley Healthcare Conference in New York, NY on Tuesday, September 15, 2009 at 3:20pm and will provide an overview on the Company's product portfolio and business developments.
InvestorSoup.com Issues Technical Trading Outlook for Cell Therapeutics Inc.
InvestorSoup.com announces an investment report featuring Cell Therapeutics Inc.
Public relations, press release distribution, investor relations, SEC filing
HAMILTON, Bermuda-- --Textainer Group Holdings Limited , the world's largest lessor of intermodal containers based on fleet size, today announce... CAMBRIDGE, Mass.-- --Vertex Pharmaceuticals Incorporated today announced that it will webcast its presentations at the Thomas Weisel Partners 2009 Healthcare Conference on... WASHINGTON-- --HHS ...
Also on Topix